Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Nordhealth AS ( (DE:6E5) ).
Nordhealth will announce its Q4 2024 results on March 4, 2025, with a live presentation and Q&A session led by CEO Charles MacBain and CFO Alexander Cram. This event highlights the company’s commitment to transparency and engagement with stakeholders, potentially impacting its market positioning and investor relations.
More about Nordhealth AS
Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS company focused on redefining digital healthcare. It develops software to empower veterinary and therapy professionals, serving over 60,000 professionals across 13,000 clinics and hospitals in more than 30 countries. Headquartered in Helsinki, Finland, Nordhealth has a strong presence in the Nordic region and is expanding internationally with 400 employees.
YTD Price Performance: -24.57%
Average Trading Volume: 300
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €257.3M
Find detailed analytics on 6E5 stock on TipRanks’ Stock Analysis page.